Xianling Ning

720 total citations
29 papers, 607 citations indexed

About

Xianling Ning is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Xianling Ning has authored 29 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Cancer Research and 9 papers in Organic Chemistry. Recurrent topics in Xianling Ning's work include Cancer, Hypoxia, and Metabolism (7 papers), ATP Synthase and ATPases Research (5 papers) and Synthesis and biological activity (4 papers). Xianling Ning is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), ATP Synthase and ATPases Research (5 papers) and Synthesis and biological activity (4 papers). Xianling Ning collaborates with scholars based in China, United States and Australia. Xianling Ning's co-authors include Yuxin Yin, Ridong Li, Yan Jin, Hailong Qi, Michael A. McNutt, Chao Tian, Zhili Zhang, Junyi Liu, Zhizhong Ma and Ying Guo and has published in prestigious journals such as Free Radical Biology and Medicine, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Xianling Ning

28 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianling Ning China 13 374 169 168 70 57 29 607
Athena Sudom United States 16 344 0.9× 210 1.2× 90 0.5× 83 1.2× 76 1.3× 21 809
Steve Perry United States 13 337 0.9× 112 0.7× 120 0.7× 34 0.5× 124 2.2× 18 737
Shu‐Ping Wang China 17 484 1.3× 101 0.6× 125 0.7× 75 1.1× 160 2.8× 36 919
Xiaoke Guo China 20 893 2.4× 270 1.6× 80 0.5× 110 1.6× 59 1.0× 69 1.1k
Irida Kastrati United States 14 376 1.0× 176 1.0× 144 0.9× 203 2.9× 42 0.7× 35 771
Esther Marco Spain 15 342 0.9× 225 1.3× 86 0.5× 117 1.7× 79 1.4× 28 789
Joana Soares Portugal 16 456 1.2× 122 0.7× 153 0.9× 265 3.8× 32 0.6× 21 713
Christopher M. Tegley United States 17 255 0.7× 290 1.7× 94 0.6× 43 0.6× 84 1.5× 22 667
Olesya A. Ulanovskaya United States 15 636 1.7× 233 1.4× 139 0.8× 134 1.9× 67 1.2× 18 925
Yinglan Jin South Korea 14 406 1.1× 153 0.9× 284 1.7× 72 1.0× 32 0.6× 19 671

Countries citing papers authored by Xianling Ning

Since Specialization
Citations

This map shows the geographic impact of Xianling Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianling Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianling Ning more than expected).

Fields of papers citing papers by Xianling Ning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianling Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianling Ning. The network helps show where Xianling Ning may publish in the future.

Co-authorship network of co-authors of Xianling Ning

This figure shows the co-authorship network connecting the top 25 collaborators of Xianling Ning. A scholar is included among the top collaborators of Xianling Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianling Ning. Xianling Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ning, Xianling, Xi Chen, Ridong Li, et al.. (2025). Identification of a novel cuproptosis inducer that induces ER stress and oxidative stress to trigger immunogenic cell death in tumors. Free Radical Biology and Medicine. 229. 276–288. 3 indexed citations
2.
Ning, Xianling, Yanqiang Zhao, Fei Xie, et al.. (2025). Thermosensitive injectable in situ forming hydrogel incorporating anti-oxidative stress and anti-inflammatory nanoparticles for vital pulp therapy of pulpitis. Materials Today Bio. 31. 101482–101482. 1 indexed citations
3.
Gong, Lidong, Xianling Ning, Junjie Huang, et al.. (2025). Molecular hybridization-driven FAK inhibitors: N-2,4-diarylaminopyrimidine-3-sulfamoyl-benzamide derivatives with improved antitumor potency. European Journal of Medicinal Chemistry. 296. 117885–117885.
4.
Li, Ridong, Lidong Gong, Junjie Huang, et al.. (2024). Discovery of 2,4-diarylaminopyrimidine derivatives bearing sulfonamide moiety as novel FAK inhibitors. Bioorganic Chemistry. 144. 107134–107134. 3 indexed citations
5.
Jia, Yue, Yaping Jiang, Xiaoqi Fan, et al.. (2024). Preoperative serum level of CA153 and a new model to predict the sub-optimal primary debulking surgery in patients with advanced epithelial ovarian cancer. World Journal of Surgical Oncology. 22(1). 64–64. 2 indexed citations
6.
Gong, Lidong, Ridong Li, Xianling Ning, et al.. (2023). Discovery of a miniaturized PROTAC with potent activity and high selectivity. Bioorganic Chemistry. 136. 106556–106556. 15 indexed citations
7.
Ning, Xianling, Hailong Qi, Ridong Li, et al.. (2022). Identification of a new small molecule that initiates ferroptosis in cancer cells by inhibiting the system Xc− to deplete GSH. European Journal of Pharmacology. 934. 175304–175304. 9 indexed citations
8.
Li, Ridong, Xianling Ning, Jianan He, et al.. (2021). Synthesis of novel sulfonamide derivatives containing pyridin-3-ylmethyl 4-(benzoyl)piperazine-1-carbodithioate moiety as potent PKM2 activators. Bioorganic Chemistry. 108. 104653–104653. 8 indexed citations
9.
Ning, Xianling, et al.. (2020). Antrodia camphorata extract (ACE)-induced apoptosis is associated with BMP4 expression and p53-dependent ROS generation in human colon cancer cells. Journal of Ethnopharmacology. 268. 113570–113570. 9 indexed citations
10.
Qi, Hailong, Xianling Ning, Xin Ji, et al.. (2019). Succinylation-dependent mitochondrial translocation of PKM2 promotes cell survival in response to nutritional stress. Cell Death and Disease. 10(3). 170–170. 77 indexed citations
11.
Zhai, Zheng, Ridong Li, Xianling Ning, et al.. (2019). Design, synthesis and biological evaluation of novel dithiocarbamate-substituted diphenylaminopyrimidine derivatives as BTK inhibitors. Bioorganic & Medicinal Chemistry. 27(18). 4124–4142. 11 indexed citations
12.
Chen, Hong, Ridong Li, Xianling Ning, et al.. (2019). Synthesis and anti-tumor efficacy of novel 2, 4-diarylaminopyrimidine derivatives bearing N-(3-pyridinylmethyl) urea moiety as anaplastic lymphoma kinase inhibitors. European Journal of Medicinal Chemistry. 178. 141–153. 7 indexed citations
13.
Su, Yue, Ridong Li, Xianling Ning, et al.. (2019). Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities. European Journal of Medicinal Chemistry. 177. 32–46. 40 indexed citations
14.
Li, Ridong, Xianling Ning, Shuo Zhou, et al.. (2017). Discovery and structure-activity relationship of novel 4-hydroxy-thiazolidine-2-thione derivatives as tumor cell specific pyruvate kinase M2 activators. European Journal of Medicinal Chemistry. 143. 48–65. 20 indexed citations
15.
Ning, Xianling, Hailong Qi, Ridong Li, et al.. (2017). Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase. European Journal of Medicinal Chemistry. 138. 343–352. 87 indexed citations
16.
Ning, Xianling, Mengmeng Yuan, Ying Guo, et al.. (2015). Neuroprotective effects of (E)-3,4-diacetoxystyryl sulfone and sulfoxide derivativesin vitromodels of Parkinson's disease. Journal of Enzyme Inhibition and Medicinal Chemistry. 31(3). 1–6. 7 indexed citations
17.
Zhang, Yu, Bin Liu, Xingyu Wu, et al.. (2015). New pyridin-3-ylmethyl carbamodithioic esters activate pyruvate kinase M2 and potential anticancer lead compounds. Bioorganic & Medicinal Chemistry. 23(15). 4815–4823. 44 indexed citations
18.
Ning, Xianling, Ying Guo, Xiaowei Wang, et al.. (2014). Design, Synthesis, and Biological Evaluation of (E)-3,4-Dihydroxystyryl Aralkyl Sulfones and Sulfoxides as Novel Multifunctional Neuroprotective Agents. Journal of Medicinal Chemistry. 57(10). 4302–4312. 62 indexed citations
19.
Ning, Xianling, Ying Guo, Xiaoyan Ma, et al.. (2013). Design, synthesis and pharmacological evaluation of (E)-3,4-dihydroxy styryl sulfonamides derivatives as multifunctional neuroprotective agents against oxidative and inflammatory injury. Bioorganic & Medicinal Chemistry. 21(17). 5589–5597. 39 indexed citations
20.
Liang, Jie, Yanglin Pan, Xianling Ning, et al.. (2006). Overexpression of PrP<sup>C</sup> and Its Antiapoptosis Function in Gastric Cancer. Tumor Biology. 27(2). 84–91. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026